Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry (HyperQ)
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55407
- Recruiting
- Minneapolis Heart Institute Foundation
-
Contact:
- Jo Anne Goldman, RT, RCIS, CCRC
- Phone Number: 612-863-3793
- Email: JoAnne.Goldman@allina.com
-
Contact:
- Rob Schwartz, MD
- Phone Number: 612-863-3823
- Email: robert.Schwartz@allina.com
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Recruiting
- Cleveland Clinic Foundation
-
Contact:
- Ritamarie F. Anselmo, BSN, RN
- Phone Number: 216-444-9229
- Email: ANSELMR@CCF.org
-
Contact:
- Cindy Stevenson, RN
- Phone Number: 216-444-9417
- Email: stevenc@CCF.org
-
Principal Investigator:
- Balaji Tamarappoo, MD, PhD
-
Sub-Investigator:
- James D. Thomas, MD, FACC
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- Recruiting
- University of Virginia
-
Contact:
- Jamie Bourque, MD
- Phone Number: 434-982-4661
- Email: jbourque@virginia.edu
-
Contact:
- Jayne Missel, RN BSN CCRC
- Phone Number: 434-243-7195
- Email: JSM3S@hscmail.mcc.virginia.edu
-
Principal Investigator:
- Jamieson Bourque, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18 years or older
- Referred for exercise MPI due to suspected coronary artery disease
Exclusion Criteria:
- Acute Coronary Syndrome (Unstable angina/NSTEMI/STEMI)
- Pre-excitation syndrome
- QRS duration > 120 ms
- Atrial Fibrillation or significant ventricular arrhythmia
- Treatment with Digoxin
- Pacemaker with 100% pacemaker dependence
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CAD status
Time Frame: one month follow up
|
The main goal of this registry will be to compare sensitivity, specificity, positive and negative predictive values of the HyperQ HFQRS analysis for detecting the presence of coronary artery disease to that of standard ECG analysis.
|
one month follow up
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jamieson M Bourque, MD, University of Virginia Health System
- Principal Investigator: Robert Schwartz, MD, Minneapolis Heart Institute Foundation
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Clin_05_01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.